艾哈迈德·奈姆（Ahmad Naim），医学博士, Vice President of US Medical Affairs at Incyte, shares how the company’s discovery expertise in immunology is fueling research aimed at delivering innovative medicines that address the unmet needs of people living with immune-mediated dermatologic conditions, including atopic dermatitis (AD) and vitiligo.